LIPOCALIN-2 Is a Major Acute-Phase Protein in a Rat and Mouse Model of Sterile Abscess
Authors:
- Matteo PascucciMPMatteo Pascucci
- Shakil AhmadSAShakil Ahmad
- Ihtzaz Ahmad MalikIMIhtzaz Ahmad Malik
- Alberto BianchiABAlberto Bianchi
- Pierluigi RamadoriPRPierluigi Ramadori
- Ghayyor AhmadGAGhayyor Ahmad
- Giuliano RamadoriGRGiuliano Ramadori
- 1 February 2012
- journal article
- Published by Wolters Kluwer Health in Shock
- Vol. 37 (2) , 191-196
Abstract
Lipocalin-2 (LCN-2) is a 25-kDa secretory protein currently used as a biomarker for renal injury and inflammation. Its source and cause of the increased serum levels are unclear. The current study compares LCN-2 gene expression with known major acute-phase proteins in the liver in a rat and mouse model of turpentine oil-induced sterile abscess. Serum LCN-2 concentrations increased dramatically up to 200-fold (20 μg/mL) at 48 h after turpentine oil injection. A strong elevation of LCN-2 mRNA in rat liver was observed starting from 4 h up to 48 h after injection, with a maximum (8,738 ± 2,104-fold) at 24 h, which was further confirmed by Western blot analysis. In contrast, the increases in gene expression of α₂-macroglobulin, the major acute-phase protein, and hemoxygenase 1, a positive acute-phase protein, were only 1,025 ± 505-fold and 47 ± 12-fold, respectively, during acute-phase reaction (APR). No considerable change was observed in LCN-2 mRNA in rat kidney and other organs as compared with liver. Using wild-type mice, a massive increase in gene expression of LCN-2, with a maximum of 2,498 ± 84-fold in liver, which is similar to that for serum amyloid A (2,825 ± 233-fold), a major mouse acute-phase protein. However, such an increase was significantly inhibited in interleukin 6 knockout mice during APR. Interleukin 6-treated rat hepatocytes induced a significant time-dependent upregulation of LCN-2.Lipocalin-2 is the major acute-phase protein in rat as compared with α₂-macroglobulin and hemoxygenase 1 and comparable with serum amyloid A in mouse whose gene expression is mainly controlled by interleukin 6. The liver is the main source of serum LCN-2 in the case of APR. ABBREVIATIONS-LCN-2-lipocalin-2-α₂M-α₂-macroglobulin-HO-1-hemoxygenase 1-IL-6-interleukin 6-SAA-serum amyloid A-TO-turpentine oil-APR-acute-phase reaction.Keywords
This publication has 23 references indexed in Scilit:
- Cellular and molecular mechanisms regulating the hepatic erythropoietin expression during acute-phase response: a role for IL-6Laboratory Investigation, 2010
- Neutrophil gelatinase-associated lipocalin (NGAL/Lcn2) is upregulated in gastric mucosa infected with Helicobacter pyloriVirchows Archiv, 2009
- Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liverExperimental and Molecular Pathology, 2007
- Changes of gene expression of iron regulatory proteins during turpentine oil-induced acute-phase response in the ratLaboratory Investigation, 2007
- Upregulation of heme oxygenase-1 gene by turpentine oil-induced localized inflammation: involvement of interleukin-6Laboratory Investigation, 2005
- Biologic markers for the early detection of acute kidney injuryCurrent Opinion in Critical Care, 2004
- Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating ironNature, 2004
- Gene expression profile favoring phenotypic reversion: a clue for mechanism of tumor suppression by NF-IL6 3′UTRCell Research, 2003
- Interleukin 6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 β and tumor necrosis factor‐αEuropean Journal of Immunology, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976